Octreotide for the Management of Chylothorax in newborns, case report
Chylothorax is the most common cause of pleural effusion in neonates. It is usually idiopathic. Neonatal chylothorax successfully respond to octreotide treatment and can reduce the duration of hospitalization. A number of therapeutic interventions have been used to reduce chyle production and promot...
Saved in:
Main Authors: | Reza Saeidi (Author), Shadi Nourizadeh (Author) |
---|---|
Format: | Book |
Published: |
Mashhad University of Medical Sciences,
2015-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Octreotide for the Management of Chylothorax in newborns, case report
by: Reza Saeidi, et al.
Published: (2015) -
Octreotide Infusion for the Treatment of Congenital Chylothorax
by: Sumayyah Ahmed Nezar Kobeisy, et al.
Published: (2020) -
Somatostatin analog (octreotide) and sirolimus immunosuppressive therapy in the treatment of chyloperitoneum and chylothorax in newborns and infants
by: Aleksandra Gurskaya, et al.
Published: (2024) -
Congenital Chylothorax in a Late Preterm Infant and Successful Treatment With Octreotide
by: Ning-Hui Foo, et al.
Published: (2011) -
Congenital Chylothorax: Case Report
by: Egemen Tolunay, et al.
Published: (2016)